Florestan Koll

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours

Ignacio Melero, María de Miguel Luken, Guillermo de Velasco et al. · Nature · 2024 · 68 citations · Full text

Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis

Florestan Koll, Séverine Banek, Luis Kluth et al. · Journal of Translational Medicine · 2023 · 47 citations · Full text

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)

Sebastian C. Schmid, Florestan Koll, Claus Rödel et al. · BMC Cancer · 2020 · 32 citations · Full text

The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer

Eva Lichtenegger, Florestan Koll, Helena Haas et al. · Human Gene Therapy · 2018 · 25 citations

Urology, Novel Therapy, Oncolytic Viruses +15

The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model

Moritz Klawitter, Ali El-Ayoubi, Jasmin Buch et al. · International Journal of Molecular Sciences · 2022 · 23 citations · Full text

Conveys Abscopal Effects, Immunology, Pathology +18